The examination of the effects of Teneligliptin on blood glucose and albuminuria in type 2 diabetic patients with nephropathy, whose glycemic control is insufficient. - The examination of the effects of Teneligliptin on blood glucose and albuminuria in type 2 diabetic patients with nephropathy, whose glycemic control is insufficient.

Kanazawa Medical University0 个研究点目标入组 50 人开始时间: 2014年12月12日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Patient who have a history of allergy to Teneligliptin. 2)Patients who have severe ketosis, diabetic coma, diabetic pre-coma, or type 1 diabetes 3)Patients who have severe infection, surgery, planned surgery, severe trauma. 4)Women who are pregnant, or possibility of pregnant, or wish to pregnant, or lactating. 5)Patients with transit disorder in the digestive tract or peptic ulcer and esophageal varix (this product may irritate affected area.) and patients whom physician judges as inappropriate 6)Patients with a predisposition to severe and habitual constipation (this product may exacerbate constipation) and patients whom physician judges as inappropriate 7)Patients who are considered unsuitable for inclusion by the attending physician.

发起方